JLE

Epileptic Disorders

MENU

Possible critical region associated with late-onset spasms in 17p13.1-p13.2 microdeletion syndrome: a report of two new cases and review of the literature Volume 24, numéro 3, June 2022

  • [1.] Giordano L, Palestra F, Giuffrida MG, Molinaro A, Iodice A, Bernardini L, et al. 17p13.1 microdeletion: genetic and clinical findings ina new patient with epilepsy and comparison with literature. Am J Med Genet A 2014; 164A(1): 225-30.
  • [2.] Adam MP, Justice AN, Schelley S, Kwan A, Hudgins L, Martin CL. Clinical utility of array comparative genomic hybridization: uncovering tumor susceptibility in individuals with developmental delay. J Pediatr 2009; 154(1): 143-6.
  • [3.] Krepischi-Santos ACV, Rajan D, Temple IK, Shrubb V, Crolla JA, Huang S, et al. Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1. Cytogenet Genome Res 2009; 125 (1): 1-7.
  • [4.] Schluth-Bolard C, Sanlaville D, Labalme A, Till M, Morin I, Touraine R, et al. 17p13.1 microdeletion involving the TP53 gene in a boy presenting with mental retardation but no tumor. Am J Med Genet A 2010; 152A(5): 1278-82.
  • [5.] Schwarzbraun T, Obenauf AC, Langmann A, Gruber-Sedlmayr Wagner K, Speicher MR, et al. Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing. J Med Genet 2009; 46(5): 341-4.
  • [6.] Komoike Y, Shimojima K, Liang JS, Fujii H, Maegaki Y, Osawa M, et al. A functional analysis of GABARAP on 17p13.1 by knockdown zebrafish. J Hum Genet 2010; 55(3): 155-62.
  • [7.] Shlien A, Baskin B, Achatz MIW, Stavropoulos DJ, Nichols KE, Hudgins L, et al. A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes. Am J Hum Genet 2010; 87(5): 631-42.
  • [8.] Zeesman S, Kjaergaard S, Hove HD, Kirchhoff M, Stevens JM, Nowaczyk MJM. Microdeletion in distal 17p13. 1: a recognizable phenotype with microcephaly, distinctive facial features, and intellectual disability. Am J Med Genet A 2012; 158A(8): 1832-6.
  • [9.] Jia JL, Chen S, Sivarajah V, Stephens D, Cortez MA. Latitudinal differences on the global epidemiology of infantile spasms: systematic review and meta-analysis. Orphanet J Rare Dis 2018; 13(1): 216.
  • [10.] Boutry-Kryza N, Labalme A, Ville D, de Bellescize J, Touraine R, Prieur F, et al. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome. Eur J Med Genet 2015; 58(2): 51-8.
  • [11.] Zeng F, Ma X, Zhu L, Xu Q, Zeng Y, Gao Y, et al. The deubiquitinase USP6 affects memory and synaptic plasticity through modulating NMDA receptor stability. PLoS Biol 2019; 17(12): e3000525.
  • [12.] Tentler D, Johannesson T, Johansson M, Råstam M, Gillberg C, Orsmark C, et al. A candidate region for Asperger syndrome defined by two 17p breakpoints. Eur J Hum Genet 2003; 11(2): 189-95.
  • [13.] Ou Z, Jarmuz M, Sparagana SP, Michaud J, Décarie JC, Yatsenko SA, et al. Evidence for involvement of TRE-2 (USP6) oncogene, low-copy repeat and acrocentric heterochromatin in two families with chromosomal translocations. Hum Genet 2006; 120(12): 227-37.